Eagle Pharmaceuticals
EGRX
#10434
Rank
S$6.33 M
Marketcap
S$0.49
Share price
0.00%
Change (1 day)
-45.14%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$6.33 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of S$6.33 Million. This makes Eagle Pharmaceuticals the world's 10434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$6.33 M-15.36%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
S$6.33 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$633.68 B 10,000,371.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$131.05 B 2,068,094.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$349.48 B 5,515,311.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
S$47.25 B 745,707.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
S$225.96 B 3,565,985.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.226 T 19,362,434.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$146.33 B 2,309,287.82%๐Ÿ‡บ๐Ÿ‡ธ USA